Emil Wohlwill, Galileo and His Battle for the Copernican System

Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG geförderten) Allianz- bzw. Nationallizenz frei zugänglich.This publication is with permission of the rights owner freely accessible due to an Alliance licence and a national licence (funded by the DFG, German Research Foundation) respectively

Clinical Validation of a Digital Transcutaneous PCO2/SpO2 Ear Sensor in Adult Patients after Cardiac Surgery

Objective: The aim of this study was to validate the V-Sign digital sensor (SenTec AG, Therweil, Switzerland) for combined noninvasive assessment of pulse oxymetric oxygen saturation (SpO2) and transcutaneous carbon dioxide tension (PtcCO2) in adults after cardiac surgery. Methods: In twenty one patients, aged 51-86years, simultaneous measurements of blood gases with the V-Sign Sensor and with two Nellcor Durasensors (model DS-100A), one at the opposite earlobe and one with a finger clip, were compared first during hyper-, normo- and hypocapnia and at different pulse rates using a pacemaker, and then at 2-h intervals up to 8h. Agreement was assessed by Bland-Altman analysis. Results: PtcCO2 data of three patients were excluded because of calibration failure of the device. Median (range) PtcCO2 for the remaining patients was 5.49 (3.3-7.6) kPa and arterial carbon dioxide tension (PaCO2) was 5.43 (3.61-7.41) kPa. Corresponding mean bias was +0.05kPa and limits of agreement (LOA) were −1.2/+1.3kPa. During normo- and hypoventilation, mean bias was good at +0.02 and +0.04kPa respectively, but limits of agreement were poor at −0.67/+0.69 and −0.81/+0.88kPa. In 10 patients, an initial overshoot of PtcCO2 was observed. Mean bias of SpO2 and pulse rate was close to zero (−1.5% and +0.001bpm respectively), but limits of agreement were unacceptably high (−21.4/+18.4% and −22.3/+22.3bpm). Conclusions: In the present state of development the SenTeC Digital monitor V-Sign device has serious limitations. Additional efforts are necessary to eliminate calibration failures and the initial overshoot of PtcCO2 as well as to improve detection of SpO2 and pulse rat

Identification of genetic elements in metabolism by high-throughput mouse phenotyping.

Metabolic diseases are a worldwide problem but the underlying genetic factors and their relevance to metabolic disease remain incompletely understood. Genome-wide research is needed to characterize so-far unannotated mammalian metabolic genes. Here, we generate and analyze metabolic phenotypic data of 2016 knockout mouse strains under the aegis of the International Mouse Phenotyping Consortium (IMPC) and find 974 gene knockouts with strong metabolic phenotypes. 429 of those had no previous link to metabolism and 51 genes remain functionally completely unannotated. We compared human orthologues of these uncharacterized genes in five GWAS consortia and indeed 23 candidate genes are associated with metabolic disease. We further identify common regulatory elements in promoters of candidate genes. As each regulatory element is composed of several transcription factor binding sites, our data reveal an extensive metabolic phenotype-associated network of co-regulated genes. Our systematic mouse phenotype analysis thus paves the way for full functional annotation of the genome

Vom Alizarinblau zum Thallin. Pharmazeutisch-chemische Forschung der BASF in den achtziger Jahren des 19. Jahrhunderts

Reinhardt C. Vom Alizarinblau zum Thallin. Pharmazeutisch-chemische Forschung der BASF in den achtziger Jahren des 19. Jahrhunderts. In: Schütt H-W, Weiss B, eds. Brückenschläge. 25 Jahre Lehrstuhl fur Geschichte der exakten Wissenschaften und der Technik an der Technischen Universitat Berlin. Berlin: Verlag fur Wissenschafts- und Regionalgeschichte; 1995: 253-276

Clinical validation of a digital transcutaneous PCO2/SpO2 ear sensor in adult patients after cardiac surgery

Objective: The aim of this study was to validate the V-Sign digital sensor (SenTec AG, Therweil, Switzerland) for combined noninvasive assessment of pulse oxymetric oxygen saturation (SpO2) and transcutaneous carbon dioxide tension (PtcCO2) in adults after cardiac surgery. Methods: In twenty one patients, aged 51-86years, simultaneous measurements of blood gases with the V-Sign Sensor and with two Nellcor Durasensors (model DS-100A), one at the opposite earlobe and one with a finger clip, were compared first during hyper-, normo- and hypocapnia and at different pulse rates using a pacemaker, and then at 2-h intervals up to 8h. Agreement was assessed by Bland-Altman analysis. Results: PtcCO2 data of three patients were excluded because of calibration failure of the device. Median (range) PtcCO2 for the remaining patients was 5.49 (3.3-7.6) kPa and arterial carbon dioxide tension (PaCO2) was 5.43 (3.61-7.41) kPa. Corresponding mean bias was +0.05kPa and limits of agreement (LOA) were −1.2/+1.3kPa. During normo- and hypoventilation, mean bias was good at +0.02 and +0.04kPa respectively, but limits of agreement were poor at −0.67/+0.69 and −0.81/+0.88kPa. In 10 patients, an initial overshoot of PtcCO2 was observed. Mean bias of SpO2 and pulse rate was close to zero (−1.5% and +0.001bpm respectively), but limits of agreement were unacceptably high (−21.4/+18.4% and −22.3/+22.3bpm). Conclusions: In the present state of development the SenTeC Digital monitor V-Sign device has serious limitations. Additional efforts are necessary to eliminate calibration failures and the initial overshoot of PtcCO2 as well as to improve detection of SpO2 and pulse rat